Khadijah Allen
Foot & Ankle Surgery · Orangeburg, SCNPI 1447498621
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Organogenesis Inc. at 27.5% of the total. 2025 is the largest year on record at $60, 2.4 times the $25 reported in 2022. That places this record below the midpoint for foot & ankle surgery clinicians in SC, where the typical reported total is $3,057.
Across 5 payments — averaging $24.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$34
- Mimedx Group, Inc.$25
- Nabriva Therapeutics, PLC$25
- Treace Medical Concepts, Inc.$21
- Averitas Pharma Inc.$19
What the payments were for
- Food & beverage$125100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 1 | $34 |
| Mimedx Group, Inc. | 1 | $25 |
| Nabriva Therapeutics, PLC | 1 | $25 |
| Treace Medical Concepts, Inc. | 1 | $21 |
| Averitas Pharma Inc. | 1 | $19 |
How this compares
$125 in reported general payments places this provider in the 5th percentile of 87 foot & ankle surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sulindac | 73 | $610 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 34 | $443 |
| Cephalexin | 47 | $285 |
| CiclopiroxCiclopirox Olamine | 23 | $245 |
| Indomethacin ErIndomethacin | 13 | $234 |
| Ciprofloxacin Hcl | 20 | $202 |
| Ketorolac Tromethamine | 14 | $180 |
| Terbinafine Hcl | 16 | $85 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Orangeburg
- Kevin RayOrangeburg$7K
- Sabina AbbasovaOrangeburg$5K
- Courtney BordenkecherOrangeburg$5K
- Ibn AnsariOrangeburg$4K
- Christine RihnOrangeburg$2K
- Benjamin OverleyHilton Head Island$643K
- Tyler GonzalezColumbia$525K
- Alison GartenRock Hill$419K
- Christopher GrossCharleston$394K
- Robert KleinGreenville$358K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.